Back to top

Eli Lilly Stock (LLY) Is Down Nearly 10% Heading into Earnings. Time to Buy?

The company’s Q2 results will be the first to include sales of its obesity pill.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

The Goldman Sachs Group, Inc. (GS)

Eli Lilly and Company (LLY)